TCL Archive Lasofoxifene Reduced Breast Cancer Risk In Postmenopausal Osteoporotic Women November 26, 2010
TCL Archive FDA Approves New Toxicology Protocol; Drug Program Under Fire; DCT Board Approves Cutbacks, Contract Concepts October 9, 1981